Literature DB >> 15034594

Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium.

Leora B Balsam1, Amy J Wagers, Julie L Christensen, Theo Kofidis, Irving L Weissman, Robert C Robbins.   

Abstract

Under conditions of tissue injury, myocardial replication and regeneration have been reported. A growing number of investigators have implicated adult bone marrow (BM) in this process, suggesting that marrow serves as a reservoir for cardiac precursor cells. It remains unclear which BM cell(s) can contribute to myocardium, and whether they do so by transdifferentiation or cell fusion. Here, we studied the ability of c-kit-enriched BM cells, Lin- c-kit+ BM cells and c-kit+ Thy1.1(lo) Lin- Sca-1+ long-term reconstituting haematopoietic stem cells to regenerate myocardium in an infarct model. Cells were isolated from transgenic mice expressing green fluorescent protein (GFP) and injected directly into ischaemic myocardium of wild-type mice. Abundant GFP+ cells were detected in the myocardium after 10 days, but by 30 days, few cells were detectable. These GFP+ cells did not express cardiac tissue-specific markers, but rather, most of them expressed the haematopoietic marker CD45 and myeloid marker Gr-1. We also studied the role of circulating cells in the repair of ischaemic myocardium using GFP+-GFP- parabiotic mice. Again, we found no evidence of myocardial regeneration from blood-borne partner-derived cells. Our data suggest that even in the microenvironment of the injured heart, c-kit-enriched BM cells, Lin- c-kit+ BM cells and c-kit+ Thy1.1(lo) Lin- Sca-1+ long-term reconstituting haematopoietic stem cells adopt only traditional haematopoietic fates.

Entities:  

Mesh:

Year:  2004        PMID: 15034594     DOI: 10.1038/nature02460

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  440 in total

Review 1.  Advances in cardiovascular molecular imaging for tracking stem cell therapy.

Authors:  Katherine J Ransohoff; Joseph C Wu
Journal:  Thromb Haemost       Date:  2010-05-10       Impact factor: 5.249

Review 2.  CD34-positive stem cells: in the treatment of heart and vascular disease in human beings.

Authors:  Alexander R Mackie; Douglas W Losordo
Journal:  Tex Heart Inst J       Date:  2011

3.  On how Rac controls hematopoietic stem cell activity.

Authors:  J A Cancelas
Journal:  Transfusion       Date:  2011-11       Impact factor: 3.157

4.  The combination of angiotensin II and 5-azacytidine promotes cardiomyocyte differentiation of rat bone marrow mesenchymal stem cells.

Authors:  YuJie Xing; AnLin Lv; Li Wang; XueBo Yan
Journal:  Mol Cell Biochem       Date:  2011-09-21       Impact factor: 3.396

Review 5.  Getting to the heart of myocardial stem cells and cell therapy.

Authors:  Tara L Rasmussen; Ganesh Raveendran; Jianyi Zhang; Daniel J Garry
Journal:  Circulation       Date:  2011-04-26       Impact factor: 29.690

6.  Bone marrow-derived cells home to and regenerate retinal pigment epithelium after injury.

Authors:  Jeffrey R Harris; Gary A J Brown; Marda Jorgensen; Shalesh Kaushal; E Ann Ellis; Maria B Grant; Edward W Scott
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-05       Impact factor: 4.799

7.  Myocardial improvement with human embryonic stem cell-derived cardiomyocytes enriched by p38MAPK inhibition.

Authors:  Yerem Yeghiazarians; Meenakshi Gaur; Yan Zhang; Richard E Sievers; Carissa Ritner; Megha Prasad; Andrew Boyle; Harold S Bernstein
Journal:  Cytotherapy       Date:  2011-10-31       Impact factor: 5.414

8.  Dual angiogenic and neurotrophic effects of bone marrow-derived endothelial progenitor cells on diabetic neuropathy.

Authors:  Jin-Ok Jeong; Mee-Ohk Kim; Hyongbum Kim; Min-Young Lee; Sung-Whan Kim; Masaaki Ii; Jung-uek Lee; Jiyoon Lee; Yong Jin Choi; Hyun-Jai Cho; Namho Lee; Marcy Silver; Andrea Wecker; Dong-Wook Kim; Young-sup Yoon
Journal:  Circulation       Date:  2009-01-26       Impact factor: 29.690

9.  Donor mesenchymal stromal cells (MSCs) undergo variable cardiac reprogramming in vivo and predominantly co-express cardiac and stromal determinants after experimental acute myocardial infarction.

Authors:  Gustavo Yannarelli; James N Tsoporis; Jean-Francois Desjardins; Xing Hua Wang; Ali Pourdjabbar; Sowmya Viswanathan; Thomas G Parker; Armand Keating
Journal:  Stem Cell Rev Rep       Date:  2014-04       Impact factor: 5.739

Review 10.  Bone marrow-derived cell therapy in chagasic cardiac disease: a review of pre-clinical and clinical results.

Authors:  Antonio Carlos Campos de Carvalho; Adriana Bastos Carvalho; Debora Bastos Mello; Regina Coeli Dos Santos Goldenberg
Journal:  Cardiovasc Diagn Ther       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.